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myocardial ischemic injury, and delivery of antegrade
cardioplegia may be compromised by some congenital
deformations, there is still a need for further improve-
ments in myocardial preservation strategies for cardiac
operations on neonates and infants.5,6
Retrograde perfusion of cardioplegic solution through
the coronary sinus has been proven to be an effective
technique for myocardial protection in adult hearts,
especially during aortic valve operations and coronary
artery bypass grafting.7-11 However, it has not been
demonstrated whether this technique can provide ade-
quate myocardial protection for neonatal and infant
hearts. Because the venous system in immature
myocardium may not develop as well as in mature
myocardium, the efficacy of retrograde cardioplegia
observed in adult hearts may not be seen in neonatal
and infant hearts. The purpose of this study was to
assess the effects of retrograde cardioplegia on myocar-
dial perfusion and energy metabolism in immature
A ntegrade cardioplegia, hypothermia, and circulatoryarrest have all been used in cardiac operations on
neonates and infants. Hypothermia and antegrade car-
dioplegia have been the primary techniques used to
minimize surgically induced myocardial ischemic
injury.1-4 Because hypothermia cannot totally prevent
Objectives: Retrograde cardioplegia has been widely used for the protection
of adult hearts during cardiac operations. Its efficacy to protect immature
myocardium is still unclear. This study was designed to assess the effects of
retrograde cardioplegia on myocardial perfusion and energy metabolism in
immature hearts.
Methods: Piglet hearts were divided into 3 groups. Hearts in group 1 were
used to assess myocardial perfusion of retrograde cardioplegia by means of
magnetic resonance imaging. Hearts in groups 2 and 3 were used to assess
the effects of retrograde cardioplegia on myocardial energy metabolism by
use of phosphorus 31 magnetic resonance spectroscopy.
Results: Magnetic resonance images showed that perfusion with retrograde
cardioplegic solution was heterogeneous. A perfusion defect was noted dur-
ing retrograde cardioplegia in the right ventricular wall and in a portion of
the posterior wall of the left ventricle in 4 of 6 hearts. Phosphorus 31 spec-
tra showed that at the end of 45-minute retrograde cardioplegia, myocardial
intracellular pH was 6.83 ± 0.17 and phosphocreatine was 53.5% ± 27% of
its prearrest value. The adenosine triphosphate level, however, remained nor-
mal throughout the retrograde cardioplegia period. Last, the hearts subject-
ed to retrograde cardioplegia or antegrade cardioplegia showed similar and
complete metabolic and functional recovery during reperfusion.
Conclusions: Retrograde cardioplegia provides heterogeneous perfusion. Its
ability to protect the right ventricular myocardium is poor and varies
between individuals. Myocardial perfusion provided by retrograde cardio-
plegia is slightly less than that needed to sustain normal myocardial energy
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hearts. Magnetic resonance (MR) imaging in combina-
tion with MR contrast agents was used to characterize
the myocardial perfusion of retrograde cardioplegia.
The ability of retrograde cardioplegia to sustain
myocardial energy metabolism was studied by using
phosphorous 31 (31P) MR spectroscopy. Antegrade car-
dioplegia was used as the control technique.
Material and methods
Isolated neonatal pig heart preparation. All animals
used in this study received humane care in compliance with
the “Guide to the Care and Use of Experimental Animals”
formulated by the Canadian Council on Animal Care.
Eighteen domestic piglets aged 5 to 11 days and weighing
3.0 to 4.5 kg were sedated with an intramuscular administra-
tion of midazolam (0.3 mg/kg body weight) and ketamine (20
mg/kg body weight). Anesthesia was maintained with 1% to
2% isoflurane in a mixture of oxygen and nitrous oxide. The
respiratory rate and volume were adjusted to keep the arteri-
al blood gases within the normal physiologic range. A ster-
notomy was performed along the midline. Anticoagulation
was provided by the injection of heparin (2000 IU) into the
superior vena cava. Heparinized cold (~4°C) cardioplegic
solution was infused into the aortic root (20 mL/kg body
weight). The hearts were then excised and mounted on a
Langendorff apparatus. A retrograde catheter with a manual-
ly inflated balloon at the tip (6F; Medtronic of Canada Ltd,
Mississauga, Ontario) was positioned into the coronary sinus
in the hearts subjected to retrograde cardioplegia. The posi-
tion of the catheter was adjusted so that the external edge of
the balloon was at the orifice of the coronary sinus. The hemi-
azygos vein was ligated. The Langendorff system was then
placed in the center of the magnet. The temperature of the
hearts was maintained at 36.5°C ± 0.5°C throughout the pro-
tocol. An in-line transonic flowmeter was used for monitor-
ing the cardioplegic delivery rate.
Experimental groups. Piglet hearts were divided into 3
groups. The hearts in group 1 (n = 6) were used to assess the
myocardial perfusion of antegrade cardioplegia and retro-
grade cardioplegia with MR perfusion imaging. All 6 hearts
in this group were subjected to antegrade cardioplegia and
retrograde cardioplegia at similar perfusion pressures (30-40
mm Hg) in a random order. An extracellular-type MR con-
trast agent (gadolinium diethylenetriamine pentaacetic acid
[Gd-DTPA]; Berlex, Montreal, Quebec, Canada) was inject-
ed into the cardioplegic lines during antegrade cardioplegia
and retrograde cardioplegia, respectively. The distribution of
the contrast agent across myocardium was monitored with
T1-weighted MR imaging. The perfusion medium containing
the contrast agents was not recirculated, so that MR contrast
agent injected during antegrade cardioplegia would have no
effect on the subsequent retrograde cardioplegia. Complete
washout of the contrast agent was also confirmed with MR
imaging before subsequent contrast injection.
The piglet hearts in groups 2 and 3 were subjected to a
protocol consisting of 30 minutes of control perfusion, 45
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minutes of cardioplegic arrest, and 30 minutes of reperfu-
sion. In the retrograde group (n = 6), cardioplegic arrest was
induced with 2-minute antegrade cardioplegia and main-
tained with 43-minute normothermic (36.5°C ± 0.5°C) ret-
rograde cardioplegia (group 2, n = 6). The hearts in group 3
(n = 6) were subjected to 45 minutes of continuous nor-
mothermic antegrade cardioplegia and used as controls. All
piglets used in this study had different mothers, and they
were assigned to the groups randomly. Myocardial energy
metabolism and intracellular pH (pHi) were monitored
throughout the protocol by 31P MR spectroscopy.
Myocardial contractile function was assessed during control
perfusion and reperfusion periods.
Perfusion media. Because the amount of blood obtained
from a piglet was not sufficient to prime the Langendorff sys-
tem, the piglet hearts in this study were perfused with modi-
fied Krebs-Henseleit solution. During cardiac arrest, the
piglet hearts were perfused with hyperkalemic Krebs-
Henseleit solution containing 100 mmol/L NaCl, 16 mmol/L
KCl, 16 mmol/L MgCl2, 0.5 mmol/L ethylenediamine
tetraacetic acid, 11 mmol/L glucose, 25 mmol/L NaHCO3,
1.75 mmol/L CaCl2, 1.2 mmol/L KH2PO4, and 0.5% bovine
serum albumin (Sigma Chemical Co, St Louis, Mo). During
the control and reperfusion periods (for groups 2 and 3), the
piglet hearts were perfused with normokalemic Krebs-
Henseleit solution containing 118 mmol/L NaCl, 3.5 mmol/L
KCl, 1.2 mmol/L MgSO4, 0.5 mmol/L ethylenediamine
tetraacetic acid, 11 mmol/L glucose, 25 mmol/L NaHCO3,
1.75 mmol/L CaCl2, 1.2 mmol/L KH2PO4, and 0.5% bovine
serum albumin. Both perfusion media were oxygenated with
95% oxygen and 5% carbon dioxide to maintain its oxygen
tension between 550 and 600 mm Hg and pH at 7.35 to 7.45.
Perfusion pressure was controlled at 30 to 40 mm Hg during
cardiac arrest (retrograde cardioplegia and antegrade cardio-
plegia) and 70 to 80 mm Hg during heart-beating periods,
respectively.
Assessment of myocardial perfusion. Distribution of ret-
rograde and antegrade cardioplegic solutions was determined
by using T1-weighted MR imaging with Gd-DTPA. During
retrograde cardioplegia and antegrade cardioplegia, 0.5 mmol
of Gd-DTPA was injected as a bolus into the perfusion line.
During its first pass, the Gd-DTPA–induced T1 signal
changes were measured by means of continuous acquisition
of 200 T1-weighted images. Because Gd-DTPA increases the
T1 signal intensities of the myocardium, bright areas in T1
images indicate the regions of perfused myocardium, where-
as dark areas reveal nonperfused myocardium.
T1-weighted imaging was performed in a 7-T, 40-cm hori-
zontal bore magnet equipped with a Biospec spectrometer
(Bruker Inc, Karlsruhe, Germany) and a Helmholtz probe
surrounding the whole heart. T1-weighted images were
acquired by means of an inversion-recovery Turbo-FLASH
sequence with a 3.6-ms echo time and a 6.4-ms repetition
time. Each image covered a 12 × 12 cm2 field of view with a
128 × 128 matrix, leading to a pixel size of 0.93 × 0.93 mm2.
All images were acquired from a 3-mm slice parallel to the
short cardiac axis.
Study of the effects of retrograde cardioplegia and ante-
grade cardioplegia on myocardial energy metabolism.
The effects of retrograde cardioplegia and antegrade cardio-
plegia on myocardial energy metabolism were studied in
groups 2 and 3 by monitoring the levels of myocardial phos-
phocreatine (PCr), inorganic phosphate (Pi), adenosine
triphosphate (ATP), and pHi by using 31P MR spectroscopy.
31P spectroscopy was performed on the magnet mentioned
above, with a Helmholtz coil surrounding the whole heart.
Free induction decay signals were obtained by using 2048
data points, a 75-microsecond pulse length, and a 2.0-second
repetition time. One hundred fifty free induction decay sig-
nals were accumulated for each spectrum over a 5-minute
period. Intracellular pH was calculated from the chemical
shift of the Pi peak relative to that of PCr.12,13 The β-peak of
ATP was used for its quantification.
Assessment of contractile function. A latex balloon with
its volume larger than that of the left ventricle (LV) was
placed inside the LV to assess myocardial function of the
hearts in groups 2 and 3. Myocardial contractile function was
evaluated by measuring LV developed pressure (LVDP) and
the maximal rate of LV pressure increase and decrease
(±dp/dt). Contractile function was also evaluated by calculat-
ing the product of LVDP and heart rate to give the rate pres-
sure product, an index of contractile work. Diastolic pressure
of the LV was set at 0 to 5 mm Hg during early period of con-
trol perfusion by inflating intraventricular balloon with water.
The balloon volume achieved at the diastolic pressure was
then kept unchanged throughout protocol.
Statistical analysis. Data are presented as means ± SD.
Statistical analyses were performed by using a statistical soft-
ware STATISTICA (StatSoft, Inc, Tulsa, Okla). Comparisons
of energy metabolites, pHi, and cardiac contractile function
between groups 2 and 3 were performed by analysis of vari-
ance with repeated measures. Significant changes in energy
metabolites, pHi, and contractile function that occurred
throughout protocol within a group of animals were deter-
mined by analysis of variance.
Results
Effects of retrograde cardioplegia and antegrade
cardioplegia on myocardial perfusion. Fig 1 shows
representative MR images acquired with Gd-DTPA
during antegrade cardioplegia (top panel) and retro-
grade cardioplegia (middle and bottom panels). As
exemplified by the image in the top panel, all the
images obtained during antegrade cardioplegia show a
uniform distribution of MR contrast agent (6/6), sug-
gesting homogeneous perfusion provided by antegrade
cardioplegia. During retrograde cardioplegia, however,
4 of 6 hearts showed dark areas in the right ventricular
(RV) free wall and in a small portion of the posterior
wall of the LV (Fig 1, middle panel). This suggests that
retrograde cardioplegia did not deliver cardioplegic
solution to these regions of the myocardium in some
hearts. In the remaining two hearts in the group, there
was a similar increase in T1 signal in both ventricular
walls during retrograde cardioplegia (Fig 1, bottom
panel), suggesting that the ability of retrograde cardio-
plegia to protect the RV wall varies between each heart.
In addition, at similar perfusion pressures, retrograde
cardioplegia provided significantly (P < .05) less car-
dioplegic flow (23.45 ± 12.31 mL/min per heart) than
that obtained with antegrade cardioplegia (96 ± 28.5
mL/min per heart).
Effect of retrograde cardioplegia and antegrade
cardioplegia on myocardial energy metabolism. The
changes in PCr, Pi, ATP, and pHi during retrograde car-
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Fig 1. Representative T1-weighted MR images obtained dur-
ing antegrade cardioplegia (AC, top panel) and retrograde
cardioplegia (RC, middle and bottom panels). Antegrade car-
dioplegia provided homogeneous perfusion across both ven-
tricular walls. Retrograde cardioplegia did not provide car-
dioplegic solution to the RV wall in some hearts.
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dioplegia and antegrade cardioplegia are shown in Figs
2 and 3. Retrograde cardioplegia resulted in a statisti-
cally significant (P < .05) decrease in PCr and an
increase in Pi levels. At the end of retrograde cardio-
plegia, the level of PCr was 53.5% ± 27.3% of its con-
trol value obtained during control perfusion.
Corresponding to the changes in PCr and Pi, the hearts
in the retrograde cardioplegia group showed a gradual
decrease in pHi (Fig 3, bottom panel). Intracellular pH
at the end of 43 minutes of retrograde cardioplegia
(6.83 ± 0.17 pH units) was significantly lower than the
control value (7.14 ± 0.10 pH units) measured during
control perfusion. These metabolic indices returned to
normal soon after reperfusion. Retrograde cardioplegia
did not result in any decline in ATP level (Fig 3, top
panel). This suggests that the energy imbalance caused
by retrograde cardioplegia was relatively mild. In con-
trast, antegrade cardioplegia resulted in a small but sig-
nificant increase in PCr and a decrease in the Pi level.
This suggests that antegrade cardioplegia at a perfusion
pressure of 30 to 40 mm Hg provides more than enough
flow to sustain normal myocardial energy metabolism.
Effect of retrograde cardioplegia and antegrade
cardioplegia on myocardial contractile function.
Contractile function of the hearts in groups 2 and 3
during control perfusion and reperfusion is summa-
rized in Fig 4. There is no significant difference in
the rate pressure product (Fig 4, top panel) or +dp/dt
Fig 2. The changes in levels of phosphocreatine (PCr, top panel) and inorganic phosphate (Pi, bottom panel) during control
perfusion, cardiac arrest, and reperfusion. Asterisks indicate a significant difference between the two groups.
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(Fig 4, bottom panel) between the two groups. Other
measures of contractile function (LVDP and –dp/dt)
were also comparable between the two groups (data
not presented). Complete recovery of contractile
function in the retrograde cardioplegia hearts during
reperfusion further suggests that retrograde cardio-
plegia can provide sufficient myocardial protection in
immature hearts, although it did not fully sustain nor-
mal myocardial energy metabolism.
Discussion
Retrograde cardioplegia has been widely accepted as
a method of myocardial protection in adult heart oper-
ations.14-16 Its efficacy to protect immature hearts has
not been demonstrated. The present study was designed
to assess the effects of retrograde cardioplegia on
myocardial perfusion and energy metabolism and to
determine whether retrograde cardioplegia can provide
adequate myocardial protection for immature hearts.
MR images show that retrograde cardioplegia does not
provide homogeneous perfusion across the myocardi-
um. The ability of retrograde cardioplegia to perfuse
the RV free wall varied significantly between individ-
ual hearts. Myocardial perfusion provided by retro-
grade cardioplegia was slightly less than that needed to
sustain normal myocardial energy metabolism under
normothermic conditions. However, the use of retro-
grade cardioplegia still resulted in complete recovery
Fig 3. The time courses of changes in ATP (top panel) and intracellular pH (bottom). Asterisks indicate a signifi-
cant difference between the two groups.
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of energy metabolism and LV contractile function dur-
ing reperfusion.
During retrograde cardioplegia, T1-weighted images
showed dark regions in the RV free walls of 4 of the 6
hearts (Fig 1, middle panel), indicating a lack of uni-
form delivery of cardioplegic solution to the RV free
wall in some immature hearts. It has been suggested
that the inability of retrograde cardioplegia to perfuse
the RV myocardium is related to the diversion of car-
dioplegic solution from the venulae and capillaries by
the thebesian vessels.17-20 This suggestion is made on
the basis of the findings that under physiologic condi-
tions the thebesian vessels help drain a considerable
amount of venous blood into the RV chamber.17 The
time course of T1 signal intensities obtained during ret-
rograde cardioplegia did not show any transient
increase of T1 signal in the RV wall (data not present-
ed), suggesting that no contrast agent reached the RV
wall. Therefore, the inability of retrograde cardioplegia
to protect the RV wall is not due to thebesian drainage.
We believe that blockage of the ostia of the coronary
veins by the retrograde balloon and opening of the
coronary veins directly to the right atrium are responsi-
ble for the lack of perfusion of the RV during retro-
grade cardioplegia.21,22 Two hearts in this group
showed similar increases in T1 signal intensities in the
Fig 4. Comparison of rate pressure product (RPP, top panel) and the rate of LV pressure increase (+dp/dt, bottom
panel) between the hearts subjected to antegrade cardioplegia and those subjected to retrograde cardioplegia.
RV (38.6 ± 15.3 AU) and LV (42.3 ± 37.15 AU) walls
during retrograde cardioplegia, indicating that the abil-
ity of retrograde cardioplegia to protect the RV
myocardium may depend on the individual heart
because of the variation in coronary venous anatomy.
To assess the metabolic effects of retrograde cardio-
plegia, 31P MR spectroscopy was used to follow
myocardial energy metabolism. We found that 43 min-
utes of normothermic retrograde cardioplegia resulted
in a decrease in PCr and pHi and an increase in Pi, sug-
gesting that the level of myocardial perfusion provided
by retrograde cardioplegia was less than that required
to sustain myocardial energy metabolism under nor-
mothermic conditions.
On the basis of the levels of high-energy phosphates,
reversible myocardial ischemia can be arbitrarily divid-
ed into 3 stages: latency, survival time, and revival
time.4 During the first period of ischemia, there are
essentially no changes in the levels of ATP, PCr, or Pi.
Oxidative phosphorylation is still the major energy
source for maintenance of myocardial homeostasis.
During the second phase of ischemia (survival time),
PCr is used to replenish ATP stores in the cytoplasm,
which leads to a decrease in PCr level accompanied by
a rise in Pi. This period ends when the PCr level
decreases to approximately 40% of its normal value. In
the present study 43 minutes of normothermic retro-
grade cardioplegia resulted in a decrease in PCr only to
53.5% ± 27.3% of its control level. In addition, the final
pHi at the end of 43 minutes of retrograde cardioplegia
(6.83 ± 0.17) was also significantly higher than the
level (pHi = 6.2 pH unit) considered indicative of
severe ischemic injury. Therefore, the levels of both
PCr and pHi suggest that ischemic changes during ret-
rograde cardioplegia were very mild. Moreover, com-
plete recovery of energy metabolism and contractile
function during reperfusion further demonstrated that
the retrograde cardioplegia–associated ischemic
changes observed in this study were not severe.
Nevertheless, the reduction in PCr and pHi is negative
in regard to myocardial protection, particularly if the
ischemic time is prolonged.
Because the piglet hearts used in this study were rel-
atively small, it was not practical to use two surface
coils to monitor myocardial energy metabolism in both
ventricular walls separately. The present 31P spec-
troscopy study used a coil surrounding the whole heart.
The observed changes in energy metabolism and intra-
cellular pH during retrograde cardioplegia and ante-
grade cardioplegia reflected the effects of the cardio-
plegic techniques on both ventricular walls. Because
RV perfusion with retrograde cardioplegia was poor in
most hearts, it is possible that the actual imbalance in
energy metabolites and intracellular pH in the LV wall
was less than that observed in the whole heart.
In this study the piglet hearts were perfused with
modified Krebs-Henseleit solution, which is probably
the major limitation of the present study. It has been
demonstrated that blood-based cardioplegia offers sev-
eral important advantages relative to crystalloid cardio-
plegia, including its higher oxygen-carrying capacity,
higher buffer capacity, more appropriate osmotic load,
endogenous oxygen-derived free radical scavengers,
and the rheologic effects of red blood cells.23-25 The lat-
ter have been suggested to play an important role in the
microcirculation.24,25 The effects of retrograde cardio-
plegia on myocardial perfusion and energy metabolism
may have been improved if blood cardioplegia had
been used in this study.
In addition, it should be mentioned that congenital
heart defects in neonates and infants may be associated
with pathologic changes in the RV, such as RV hyper-
trophy and pulmonary hypertension. These pathologic
changes may compromise the efficacy of retrograde
cardioplegia. Therefore, extrapolation of the results of
this study into clinical situations should be done with
caution.
In summary, under similar perfusion pressures,
myocardial perfusion provided by retrograde cardio-
plegia is slightly less than that needed to sustain normal
myocardial energy under normothermic conditions;
however, it is sufficient for complete metabolic and
functional recovery. The ability of retrograde cardio-
plegia to perfuse the RV myocardium is poor and varies
between individuals.
We acknowledge the technical assistance of Mrs Lori
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